Skip to main content
Premium Trial:

Request an Annual Quote

Susan Siegel

Illumina has named Susan Siegel to its board of directors. Siegel is chief innovation officer at General Electric and CEO of GE Ventures, which invests in startups and commercializes GE's intellectual property. Prior to joining GE, she was a general partner at Mohr Davidow Ventures, where she led investments in personalized medicine, digital health, and life sciences. Siegel was a founding representative member of the National Institutes of Health's National Center for Advancing Translational Sciences and also served on the Precision Medicine Initiative Working Group of the Advisory Committee to the NIH Director.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.